David Mezebish MD in Rockville, Maryland

Home Maryland Rockville

David Mezebish MD has Dermatology as his primary medical specialty. Their primary office is: 9711 Medical Ctr Dr in Rockville, Maryland. There is an additional office location, for a total of two, for David Mezebish MD that can be viewed further down.

They're a part of the: Maryland Skin Cancer Specialists, Pa medical group which has around 2 members. You can call their office at 240-453-0050 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Uniformed Services Uhs Fe Hebert School Of Med and graduated in 1990 (around 34 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

David Samuel Mezebish MD Office Phone and Directions

David Mezebish MD
Maryland Skin Cancer Specialists, Pa
9711 Medical Ctr Dr
Rockville, Maryland 20850
240-453-0050

Patient Ratings
Please rate your experience with David Mezebish MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 240-453-0050

Enter a starting address:

Healthcare Info for David Mezebish MD

Additional Medical Specialties Include:
MICROGRAPHIC DERMATOLOGIC SURGERY (MDS)

Medical School: Uniformed Services Uhs Fe Hebert School Of Med
Graduation Year: 1990
The Primary Medical Specialty for David Mezebish MD is listed as: Dermatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 34
PAC (PECOS ID)#: 2860382124
NPI #: 1720059736
NPI Created On: 01/28/2006
NPI Last Updated Listed as: 01/25/2023
Primary Taxonomy Code: 207ND0900X
License Number:
0101232840
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

CareFirst BlueChoice, Inc.
Group Hospitalization and Medical Services Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English,Spanish, Spanish.

Services and Procedures include:

Tangential biopsy of single skin lesion
Tangential biopsy of additional skin lesion
Removal of malignant growth (over 4.0 centimeters) of the trunk, arms, or legs
Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
Repair of wound (2.6 to 7.5 centimeters) of neck, hands, feet, and/or genitals
Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth
Repair of wound (2.6 to 7.5 centimeters) of trunk
Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs
Repair of wound of scalp, arms, and/or legs
Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet
Repair of wound (2.6 to 7.5 centimeters) of eyelids, nose, ears, and/or lips
Tissue transfer repair of wound (10 sq centimeters or less) of eyelids, nose, ears, and/or lips
Destruction of skin growth
Destruction of 2-14 skin growths
Destruction of 15 or more skin growths
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks)
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals
Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks)
Removal and microscopic examination of growth of the trunk, arms, or legs
Biopsy of ear

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $9

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 786881211

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: DERMATOLOGY

Name of Drug #1: BF-RhodoLED

Drug or Biological: Device

Product Category #2: DERMATOLOGY

Name Of Drug #2:: XEPI